vs

Side-by-side financial comparison of ORION ENERGY SYSTEMS, INC. (OESX) and Avidity Biosciences, Inc. (RNA). Click either name above to swap in a different company.

ORION ENERGY SYSTEMS, INC. is the larger business by last-quarter revenue ($21.1M vs $12.5M, roughly 1.7× Avidity Biosciences, Inc.). ORION ENERGY SYSTEMS, INC. runs the higher net margin — 0.8% vs -1398.3%, a 1399.1% gap on every dollar of revenue. On growth, Avidity Biosciences, Inc. posted the faster year-over-year revenue change (434.0% vs 7.7%). ORION ENERGY SYSTEMS, INC. produced more free cash flow last quarter ($-1.1M vs $-156.9M). Over the past eight quarters, Avidity Biosciences, Inc.'s revenue compounded faster (138.5% CAGR vs -10.6%).

Orion Energy Systems, Inc. is an American LED lighting and intelligent controls enterprise, founded in Plymouth, Wisconsin, and headquartered in Manitowoc, Wisconsin

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

OESX vs RNA — Head-to-Head

Bigger by revenue
OESX
OESX
1.7× larger
OESX
$21.1M
$12.5M
RNA
Growing faster (revenue YoY)
RNA
RNA
+426.3% gap
RNA
434.0%
7.7%
OESX
Higher net margin
OESX
OESX
1399.1% more per $
OESX
0.8%
-1398.3%
RNA
More free cash flow
OESX
OESX
$155.7M more FCF
OESX
$-1.1M
$-156.9M
RNA
Faster 2-yr revenue CAGR
RNA
RNA
Annualised
RNA
138.5%
-10.6%
OESX

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
OESX
OESX
RNA
RNA
Revenue
$21.1M
$12.5M
Net Profit
$160.0K
$-174.4M
Gross Margin
30.9%
Operating Margin
1.8%
-1513.5%
Net Margin
0.8%
-1398.3%
Revenue YoY
7.7%
434.0%
Net Profit YoY
110.6%
-117.0%
EPS (diluted)
$0.04
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OESX
OESX
RNA
RNA
Q4 25
$21.1M
Q3 25
$19.9M
$12.5M
Q2 25
$19.6M
$3.8M
Q1 25
$20.9M
$1.6M
Q4 24
$19.6M
$3.0M
Q3 24
$19.4M
$2.3M
Q2 24
$19.9M
$2.0M
Q1 24
$26.4M
$3.5M
Net Profit
OESX
OESX
RNA
RNA
Q4 25
$160.0K
Q3 25
$-581.0K
$-174.4M
Q2 25
$-1.2M
$-157.3M
Q1 25
$-2.9M
$-115.8M
Q4 24
$-1.5M
$-102.3M
Q3 24
$-3.6M
$-80.4M
Q2 24
$-3.8M
$-70.8M
Q1 24
$1.6M
$-68.9M
Gross Margin
OESX
OESX
RNA
RNA
Q4 25
30.9%
Q3 25
31.0%
Q2 25
30.1%
Q1 25
27.4%
Q4 24
29.4%
Q3 24
23.1%
Q2 24
21.6%
Q1 24
25.8%
Operating Margin
OESX
OESX
RNA
RNA
Q4 25
1.8%
Q3 25
-1.2%
-1513.5%
Q2 25
-5.2%
-4448.7%
Q1 25
-12.7%
-8360.9%
Q4 24
-6.4%
-4069.6%
Q3 24
-16.9%
-4200.9%
Q2 24
-17.2%
-4040.4%
Q1 24
6.8%
-2178.6%
Net Margin
OESX
OESX
RNA
RNA
Q4 25
0.8%
Q3 25
-2.9%
-1398.3%
Q2 25
-6.4%
-4089.3%
Q1 25
-13.9%
-7360.0%
Q4 24
-7.7%
-3439.5%
Q3 24
-18.7%
-3441.7%
Q2 24
-18.9%
-3461.8%
Q1 24
6.1%
-1943.4%
EPS (diluted)
OESX
OESX
RNA
RNA
Q4 25
$0.04
Q3 25
$-0.17
$-1.27
Q2 25
$-0.04
$-1.21
Q1 25
$1.32
$-0.90
Q4 24
$-0.46
$-0.80
Q3 24
$-1.10
$-0.65
Q2 24
$-0.12
$-0.65
Q1 24
$0.06
$-0.79

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OESX
OESX
RNA
RNA
Cash + ST InvestmentsLiquidity on hand
$4.7M
$350.2M
Total DebtLower is stronger
$9.8M
Stockholders' EquityBook value
$11.8M
$1.9B
Total Assets
$48.3M
$2.1B
Debt / EquityLower = less leverage
0.83×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OESX
OESX
RNA
RNA
Q4 25
$4.7M
Q3 25
$5.2M
$350.2M
Q2 25
$3.6M
$243.9M
Q1 25
$6.0M
$254.2M
Q4 24
$7.5M
$219.9M
Q3 24
$5.4M
$370.2M
Q2 24
$5.7M
$575.8M
Q1 24
$5.2M
$471.4M
Total Debt
OESX
OESX
RNA
RNA
Q4 25
$9.8M
Q3 25
$9.9M
Q2 25
$8.5M
Q1 25
$10.3M
Q4 24
Q3 24
$12.5M
Q2 24
$13.5M
Q1 24
$10.0M
Stockholders' Equity
OESX
OESX
RNA
RNA
Q4 25
$11.8M
Q3 25
$11.4M
$1.9B
Q2 25
$10.8M
$1.2B
Q1 25
$11.9M
$1.3B
Q4 24
$14.5M
$1.4B
Q3 24
$15.8M
$1.5B
Q2 24
$19.1M
$1.2B
Q1 24
$22.5M
$830.9M
Total Assets
OESX
OESX
RNA
RNA
Q4 25
$48.3M
Q3 25
$47.9M
$2.1B
Q2 25
$49.0M
$1.4B
Q1 25
$52.5M
$1.5B
Q4 24
$52.7M
$1.6B
Q3 24
$56.3M
$1.6B
Q2 24
$59.8M
$1.3B
Q1 24
$63.2M
$951.5M
Debt / Equity
OESX
OESX
RNA
RNA
Q4 25
0.83×
Q3 25
0.87×
Q2 25
0.79×
Q1 25
0.87×
Q4 24
Q3 24
0.79×
Q2 24
0.71×
Q1 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OESX
OESX
RNA
RNA
Operating Cash FlowLast quarter
$-897.0K
$-156.2M
Free Cash FlowOCF − Capex
$-1.1M
$-156.9M
FCF MarginFCF / Revenue
-5.4%
-1257.6%
Capex IntensityCapex / Revenue
1.2%
5.7%
Cash ConversionOCF / Net Profit
-5.61×
TTM Free Cash FlowTrailing 4 quarters
$-905.0K
$-592.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OESX
OESX
RNA
RNA
Q4 25
$-897.0K
Q3 25
$1.8M
$-156.2M
Q2 25
$-515.0K
$-199.7M
Q1 25
$-699.0K
$-124.8M
Q4 24
$3.8M
$-99.9M
Q3 24
$498.0K
$-65.6M
Q2 24
$-3.0M
$-65.0M
Q1 24
$175.0K
$-70.4M
Free Cash Flow
OESX
OESX
RNA
RNA
Q4 25
$-1.1M
Q3 25
$1.6M
$-156.9M
Q2 25
$-570.0K
$-203.0M
Q1 25
$-750.0K
$-128.6M
Q4 24
$3.7M
$-103.8M
Q3 24
$493.0K
$-67.3M
Q2 24
$-3.0M
$-65.5M
Q1 24
$144.0K
$-71.3M
FCF Margin
OESX
OESX
RNA
RNA
Q4 25
-5.4%
Q3 25
7.9%
-1257.6%
Q2 25
-2.9%
-5277.1%
Q1 25
-3.6%
-8174.3%
Q4 24
19.1%
-3491.0%
Q3 24
2.5%
-2881.8%
Q2 24
-15.0%
-3204.6%
Q1 24
0.5%
-2012.3%
Capex Intensity
OESX
OESX
RNA
RNA
Q4 25
1.2%
Q3 25
1.3%
5.7%
Q2 25
0.3%
86.9%
Q1 25
0.2%
238.6%
Q4 24
0.1%
131.7%
Q3 24
0.0%
72.9%
Q2 24
0.1%
26.0%
Q1 24
0.1%
25.8%
Cash Conversion
OESX
OESX
RNA
RNA
Q4 25
-5.61×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OESX
OESX

Lighting Product And Installation$11.9M56%
Electric Vehicle Charging Systems$4.7M22%
Maintenance Services$4.4M21%

RNA
RNA

Segment breakdown not available.

Related Comparisons